• Bifidobacterium vs. FMT: Imaging Neuroinflammation in HE Rat

  2026-04-20

  This study pioneers the use of [18F]PBR146 micro-PET/CT imaging to assess and compare the effects of Bifidobacterium and fecal microbiota transplantation (FMT) on neuroinflammation in rat models of chronic hepatic encephalopathy (HE). Findings demonstrate region-specific neuroinflammation reduction with Bifidobacterium, while FMT showed no positive effect, highlighting important considerations for gut–liver–brain axis research.

• Optimizing Cell Assays with EZ Cap™ Firefly Luciferase mRNA

  2026-04-20

  This article explores real-world laboratory scenarios where EZ Cap™ Firefly Luciferase mRNA (5-moUTP) (SKU R1013) addresses reproducibility, sensitivity, and workflow reliability in cell viability and translation efficiency assays. Evidence-backed protocol guidance and vendor comparisons are provided to support experimental success.

• NAD+/NADH Balance Governs Fungal Metabolic Adaptation to Hyp

  2026-04-19

  This review elucidates how NAD+/NADH homeostasis orchestrates the metabolic adaptation of filamentous fungi to hypoxic environments, regulating key pathways in energy metabolism and secondary metabolite biosynthesis. Insights into redox-driven switches highlight broader applications for metabolic and cancer biology research.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance via PI3

  2026-04-18

  This study elucidates how RCN2 promotes metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) by facilitating UBR5-mediated ubiquitination and degradation of PPP2CA, thereby activating the PI3K-AKT signaling pathway. These findings provide a mechanistic foundation for targeting the RCN2-PPP2CA-PI3K-AKT axis as a therapeutic strategy to overcome treatment resistance in ESCC.

• Acifran: Structural Insights and Selectivity in Lipid Metabo

  2026-04-17

  Discover how Acifran, a selective (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid, advances lipid metabolism research by revealing the molecular basis of GPCR selectivity. This article uniquely dissects structural mechanisms, guiding optimal assay design and future therapeutic exploration.

• Catalpol (N1352): Practical Guide for Disease Model Research

  2026-04-16

  Catalpol (N1352) is a high-purity iridoid glycoside for mechanistic studies in neuroprotection, osteoporosis, ischemic stroke, and liver fibrosis models. Researchers should rely on established dosing and solubility parameters, as unsupported or speculative uses are discouraged. Optimal outcomes depend on strict adherence to technical guidance and awareness of compound-specific limitations.

• Gepotidacin in Antibacterial Research: Protocols & Troublesh

  2026-04-15

  Gepotidacin (GSK2140944) transforms antibacterial research with a unique mechanism targeting bacterial DNA replication. This article delivers practical workflows, advanced use-cases, and experimental troubleshooting for maximizing Gepotidacin’s impact, especially against drug-resistant pathogens.

• Abiraterone Acetate: Potent CYP17 Inhibitor for Prostate Can

  2026-04-14

  Abiraterone acetate is a selective CYP17 inhibitor widely used in prostate cancer research, especially for castration-resistant models. It shows high potency and specificity, enabling robust inhibition of androgen biosynthesis. This article details its mechanism, evidence base, and integration protocols.

• Gallein: G Protein βγ Subunit Inhibitor in Translational Ass

  2026-04-13

  Gallein, a potent G protein βγ subunit inhibitor from APExBIO, is redefining experimental workflows in cancer, immunology, and metabolic disease research. This guide translates core findings and protocol optimizations into actionable steps, empowering researchers to harness precise GPCR signaling modulation for robust, reproducible results.

• Dopamine Inhibits Osteoclastogenesis via cAMP/PKA/CREB Pathw

  2026-04-12

  Wang et al. (2021) provide mechanistic evidence that dopamine suppresses osteoclast differentiation by inhibiting the cAMP/PKA/CREB signaling axis in bone-resorbing cells. This study clarifies a key neuro-osteological pathway and offers actionable insights for researchers dissecting cAMP-dependent mechanisms in bone biology.

• UTP Solution (100 mM): Precision Nucleotide for Next-Gen Epi

  2026-04-12

  Explore how UTP Solution (100 mM) powers next-generation epigenetic and RNA research with unmatched purity and application specificity. Discover unique insights into monogenic gene expression and practical assay decisions.

• U 46619: Applied Workflows for Platelet and Renal Research

  2026-04-11

  U 46619 (11,9 epoxymethano-prostaglandin H2) is a precision tool for dissecting platelet aggregation, serotonin release, and renal vascular responses. This guide delivers actionable protocols, advanced troubleshooting, and context-rich experimental strategies, enabling robust, reproducible results in cardiovascular and kidney research.

• HATU in Peptide Synthesis Chemistry: Applied Protocols & Tro

  2026-04-11

  HATU enables rapid, high-yield amide and ester bond formation in peptide synthesis—outperforming traditional coupling reagents for challenging substrates. This guide delivers actionable protocols, troubleshooting strategies, and insights from recent breakthrough studies, making it essential for researchers seeking reliability and efficiency in advanced synthesis workflows.

• Scenario-Driven Laboratory Solutions with Gepotidacin (SK...

  2026-04-10

  This article delivers a scenario-based, evidence-driven exploration of Gepotidacin (SKU BA1220) for antibacterial research workflows. By addressing real challenges in cell viability, cytotoxicity, and resistance profiling, it demonstrates how Gepotidacin supports reproducible, quantitative outcomes for bench scientists. Actionable guidance is provided for optimizing protocol design and product selection.

• Neticonazole Hydrochloride (SKU C8715): Reliable Dual-Act...

  2026-04-09

  This article addresses real laboratory scenarios where Neticonazole Hydrochloride (SKU C8715) delivers validated, dual-action solutions for antifungal and colorectal cancer workflows. Drawing on quantitative data, literature, and direct comparison, it offers practical guidance for cell-based assays, protocol optimization, and vendor selection. Explore how SKU C8715 empowers reproducibility and data integrity in both cytotoxicity and exosome inhibition studies.

437 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page